Effect of Fremanezumab Compared With Placebo for Prevention of Episodic Migraine: A Randomized Clinical Trial

IMPORTANCE: Fremanezumab, a fully humanized monoclonal antibody that targets calcitonin gene-related peptide, may be effective for treating episodic migraine. OBJECTIVE: To assess the efficacy of fremanezumab compared with placebo for prevention of episodic migraine with a monthly dosing regimen or...

Full description

Saved in:
Bibliographic Details
Published in:JAMA
Main Authors: Dodick, David W., Silberstein, Stephen D., Bigal, Marcelo E., Yeung, Paul P., Goadsby, Peter J., Blankenbiller, Tricia, Grozinski-Wolff, Melissa, Yang, Ronghua, Ma, Yuju, Aycardi, Ernesto
Format: Artigo
Language:Inglês
Published: American Medical Association 2018
Subjects:
Original Investigation
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6583237/
https://ncbi.nlm.nih.gov/pubmed/29800211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2018.4853
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items